Search results

Page results

• Lower Gastrointestinal suspected cancer pathway

  This page is for patients who have been referred on a suspected cancer pathway.

• History making decision announced for Thalassaemia patients!

  Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over. 

• COVID-19 NHS vaccination centre to reopen at Islington Business Design Centre

  UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.

• Musculoskeletal Outpatient Therapy Service (UCH)

  The musculoskeletal (MSK) outpatient therapy service at University College Hospital provides assessment and treatment of patients for a variety of specialities including orthopaedic, rheumatology, hand therapy, women’s health, orthotic, podiatry and spinal non-operative and operative patients with musculoskeletal dysfunction.

• New UCLH clinic opens to provide COVID-19 treatments for highest risk non-hospitalised patients

  University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.

• Having proton beam therapy: information for children aged 5-8

  Having proton beam therapy: information for children aged 5-8 patient information page.

• UCLH researchers find way to reduce side effects of treatment for adrenal disorder

  A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.

• Having proton beam therapy: information for children aged 9-12

  Having proton beam therapy: information for children aged 9-12 patient information

• Having proton beam therapy: information for teenagers aged 13-17

  Having proton beam therapy: information for teenagers aged 13-17 patient information.

• High blood pressure and its drug treatment unlikely to increase entry of COVID-19 virus into cells

  Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.